Share Name Share Symbol Market Type Share ISIN Share Description
Convatec LSE:CTEC London Ordinary Share GB00BD3VFW73 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.10p -0.54% 202.10p 202.00p 202.20p 203.60p 201.50p 203.30p 1,913,032 12:07:58
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 1,688.3 -125.8 -15.0 - 3,943.93

Convatec Share Discussion Threads

Showing 176 to 199 of 200 messages
Chat Pages: 8  7  6  5  4  3  2  1
DateSubjectAuthorDiscuss
06/11/2017
19:55
UBS has upgraded CTEC to buy. This hopefully is the begining of share recovering some of its loses.
karateboy
03/11/2017
15:03
This is getting battered - RSI is ripe for jump in share price ....takeover territory I reckon.
mbmiah
01/11/2017
19:00
RNS..release after 3pm this afternoon, i missed it! CFO has purchased 100,000 shares. On 30 and 31 October 2017 Frank Schulkes, the Company's Chief Financial Officer and a PDMR, purchased Shares in the Company as follows; 30 October 2017 - 50,000 Shares at £2.014399 per share. 31 October 2017 - 50,000 Shares at £1.959335 per share. Mr Schulkes' resulting shareholding is 100,000 Shares.
citytrader66
23/10/2017
12:28
Daily Mail/This is Money : 19 October 2017 DIRECTOR'S DEALS: Convatec chairman Sir Christopher Gent buys nearly £83,000 worth of shares City grandee Sir Christopher Gent spent nearly £83,000 buying shares in Convatec after it lost more than a fifth of its value in a day. In a vote of confidence in the medical products firm, the chairman bought 38,889 shares at 213p. That followed a 26.6 per cent slump in the share price on Monday, after Convatec slashed its sales forecasts for the year amid supply issues and disappointing revenues. Gent is a former chief executive of Vodafone and an ex-chairman of GlaxoSmithKline. Read more: http://www.thisismoney.co.uk/money/markets/article-4998318/DIRECTOR-S-DEALS-Convatec-chairman-Sir-Christopher-Gent.html#ixzz4wKkFv63p
analyzer
16/10/2017
21:58
i think it will trade in a +-10p range for a few days or even weeks before some recovery. i bought today at 203.50p one minute before the close!
citytrader66
16/10/2017
21:24
Does anyone think this is a good buy at its current price, or will it drop more tomorrow?
polecat70
16/10/2017
21:16
RSI 14.97 indicates oversold?
citytrader66
16/10/2017
20:29
6 month RSI still indicates more selling to come
mbmiah
16/10/2017
18:19
Any company who disappoints get smashed, 185p my target.
montyhedge
16/10/2017
14:02
Private investors stuffed yet again - Take care when Private Equity houses sell down - They normally know what they are doing and have seen rough water in the near or middle future (imo)
pugugly
16/10/2017
13:46
FY2017 guidance and third quarter update 16 OCTOBER 2017 (LSE: CTEC) ConvaTec Group Plc ("the Group") is today providing an update on trading in the third quarter and revising guidance for full year expectations for organic revenue growth and delivery of the Margin Improvement Programme ("MIP Programme"). In the third quarter, Group revenue was $445.5 million, reflecting 6.8% reported growth on the same period in 2016, 5.1%[1] at constant exchange rates and 3.3%[2] organic growth. The Group also continued to expand its product portfolio across products and geographies. However, performance during the third quarter was severely impacted by supply issues in both Advanced Wound and Ostomy Care, and a lower than anticipated revenue contribution from new products. Consequently, the Group now anticipate full year organic revenue growth will be between 1% and 2%, with the outcome in this range being dependent on the degree of success in resolving remaining supply issues, fulfilment of backorders and recovery of orders in both Advanced Wound and Ostomy Care in the fourth quarter. RNS link below ... hTTps://www.investegate.co.uk/convatec-group-plc--ctec-/rns/fy2017-guidance-and-third-quarter-update/201710160700046324T/
peterbill
15/9/2017
16:18
So what are the main worries for investors guys?
gswredland
15/9/2017
15:08
I think we will. I sold out for small profit a few weeks ago. First bought in at 247 then made mistake, as it turned out of averaging up. Still think long-term will be a good investment once debt levels are reduced and if I still held my original purchase only I would probably have hung on. Probably. GLA.
keyno
15/9/2017
13:42
250 if you can get it
mbmiah
15/9/2017
12:16
Chart looking very weak. Might head back to the price it was floated at. Which I believe was around 230p
gateside
15/9/2017
10:04
Is 250 still a good entry point?
keyno
06/9/2017
20:55
Also they face strong competition from SN. in the advanced wound care market.
gateside
06/9/2017
20:53
Q1 results for 2017, saw operating profits fall by 8.5%
gateside
06/9/2017
18:49
No idea. This is just a quiet, boring old stock in the wrong direction I'm afraid. Just have to wait for the U-turn.
mbmiah
06/9/2017
15:07
Well looks as if 250 is on it's way guys! Any ideas as to why it is falling?
gswredland
01/9/2017
14:26
Agree 250p could be a good entry point.
gateside
14/8/2017
22:09
Am I the only one left holding these? I've not got the shares themselves, but £30 spread bets. John
2350220
11/8/2017
12:27
250 re entry target. Should get that before santa rally IMO
mbmiah
10/8/2017
10:14
Look at the rate of return on capital and the cash flow as debt is so cheap (at the moment) that this is not a problem. Its a well structured business and a pity we can't get a copy of Peel Hunt report as they will have mentioned this.
anley
Chat Pages: 8  7  6  5  4  3  2  1
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V: D:20171215 12:23:37